Dalbavancin - NDC Database
4 records found
Page:
0480-3325 Oct 29, 2025
Dalbavancin 500 mg/25ml Intravenous Injection, Powder, for Solution by Teva Pharmaceuticals, Inc.
Dalbavancin 500 mg/25ml Intravenous Injection, Powder, for Solution by Teva Pharmaceuticals, Inc.
57970-100 May 23, 2014
Dalvance 500 mg/25ml Intravenous Injection, Powder, for Solution by Durata Therapeutics Inc.
Dalvance 500 mg/25ml Intravenous Injection, Powder, for Solution by Durata Therapeutics Inc.
65219-120 Nov 10, 2025
Dalbavancin Hydrochloride 500 mg/25ml Intravenous Injection, Powder, for Solution by Fresenius Kabi USA, LLC
Dalbavancin Hydrochloride 500 mg/25ml Intravenous Injection, Powder, for Solution by Fresenius Kabi USA, LLC
71288-034 Nov 26, 2025
Dalbavancin 500 mg/25ml Intravenous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc
Dalbavancin 500 mg/25ml Intravenous Injection, Powder, Lyophilized, for Solution by Meitheal Pharmaceuticals Inc
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.